Science and Technology Committee

7 July 2026

Science and Technology Committee House of Lords

00:03 - 01:40
Speaker 2
Morning, welcome to this Select Committee on Science and Technology.  We are proceeding with our inquiry into innovation in the NHS, specifically concerning personalised medicines and AI.  We're very pleased to have as our witness this morning Preet Kaur Gill, who is the Parliamentary Under-Secretary of State, Department of Health and Social Care.  And with her are two of her colleagues, Fiona Bride, the Interim Director General for Commercial and Growth, Department of Health and Social Care and NHS England, and Rob Thompson, Chief Digital, Data and Technology Officer, Department of Health and Social Care and NHS England.  Thank you all for coming. 

We have quite a number of questions for you.  So as you know, our inquiry has chosen to look at innovation in the NHS through the lens of two major healthcare technologies: personalised medicines and AI for healthcare.  The 10-year health plan describes an ambition to, and I quote, "establish a genomics population health service and make the NHS the most AI-enabled care system in the world."  So the first question that we have is what are the government's ambitions for these two technologies and what progress are you making to deliver on these?  So Minister, would you like to start? 
01:40 - 02:51
Speaker 1
Yes, thank you so much, Chair, and thank you for the opportunity to give evidence today.  As you know, we're at a really important moment, I would say, for the NHS because innovation isn't just about new technology, it's about how do we actually improve outcomes for patients, how do we support the workforce, and how do we build a health service that is able to prevent illness earlier and clearly deliver care more effectively.  And that's the premise by which I approach this.  I think when we talk about innovation, I think it is important to separate the two areas, whilst they're often discussed together and I get why they are, but they're not the same.  You've got personalised medicine and then you've got artificial intelligence. 

And so they are both built on, of course, the advances of science, of data and technology, but I suppose they answer different questions.  So let me take those separately.  So personalised medicine is about patients getting the right treatment to the right person at the right time.  And we know that healthcare has often relied far too much on a one-size-fits-all approach.  But every patient is different. 

The rest of the transcript is for Pro customers

Unlock the full transcript, chat, and every analysis feature with Polyfact Pro.

The video itself stays free to watch, in full, no account needed.